Ongoing Task Forces

Adjuvants in Allergen Immunotherapy Task Force

aiait
Introduction

The AiAIT task force aims to critically discuss the role of adjuvants and carriers in allergen immunotherapy, both in the context of tolerance induction or novel vaccination concepts. The Task force Adjuvants in Allergy was approved in November 2016.

Aims:
·         To evaluate the state of the art in established adjuvants
·         To determine the immune effects associated with adjuvants
·         To evaluate their risks and outweigh with the benefits
·         To critically assess novel adjuvants and formulations potentially suitable in AIT

Deliverables and Timelines:
1)      The task force will be constituted in the EAACI Helsinki Meeting in 2017.
2)      A workshop is planned for the preparation of a first EAACI position paper to be delivered in 2018.

Task Force members
Thomas Kundig and Erika Jensen Jarolim

Picture: TF secretary Erika Jensen-Jarolim with TF chair Thomas Kündig

Board Members:

Chair
Thomas Kündig
Head of Research, Dept. of Dermatology
Univ. Hospital Zurich
Zurich, Switzerland
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Secretary
Erika Jensen-Jarolim, MD.
Head of Comparative Medicine,
Inst. of Pathophysiology and Allergy Research,
Center of Pathophysiology, Infectiology and Immunology
Medical University Vienna
Vienna, Austria
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Oliver Pfaar
Department of Otorhinolaryngology
Head and Neck Surgery,
Universitätsmedizin Mannheim
Medical Faculty Mannheim
Heidelberg University
Germany

Center for Rhinology and Allergology
Wiesbaden
Germany
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Ralph Mösges
Institute for Medical Statistics, Informatics and Epidemiology
University Clinics Köln
Cologne, Germany
E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Ludger Klimek
Head Center of Rhinology and Allergology,
Wiesbaden, Germany
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Robin O´Hehir
Director, Department of Allergy, Immunology and Respiratory Medicine,
Alfred Hospital, and
Monash University
Australia
Email: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it.

Harald Renz
University Clinics Marburg
Head Lab medicine, Patobiochemistry and Moleular Biology
Marburg, Germany
Email: harald.renz @uk-gm.de

Claudio Rhyner
Swiss Institute of Allergy and Asthma Research
Davos, Switzerland
Phone: +41 (0) 81 410 08 51
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Franziska Roth-Walter
The interuniversity Messerli Research Institute,
Univ. of Veterinary Medicine Vienna
Medical University Vienna
University Vienna
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Johannes Savolainen
‪Faculty of Medicine‪
Pulmonary Diseases and Clinical Allergology
University of Turku, Finland
Phone: 02 3132564,
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Gabriela Senti
Director Research and Education
Head Clinical Trials Center

University Hospital Zurich

Zurich, Switzerland
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Claudia Traidl-Hoffmann
Univ.-Prof. Dr. med. Claudia Traidl-Hoffmann,
Direktorin, Institut für Umweltmedizin, Technische Universität München
Germany
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Sergio Bonini
Institute of Translational Pharmacology,
Italian National Research Council, Rome, Italy
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Marek Jutel,
1.) Wroclaw Medical University, Department of Clinical Immunology, Wrocław, Poland
2.) ALL-MED Medical Research Institute,Wroclaw; Poland
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Lars Jacobsen
Copenhagen University
Copenhagen Area, Capital Region, Denmark
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Vera Mahler
Head of Division Allergology
Paul-Ehrlich-Institute
Federal Institute for Vaccines and Biomedicines
Langen, Germany
Email This email address is being protected from spambots. You need JavaScript enabled to view it.

Philippe Moingeon
Head of Department on autoimmune diseases
Research and Development,
Servier, 50 rue Carnot, 92150 Suresnes, France.
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Oscar Palomares
Dpto. Bioquímica y Biología Molecular, Fac. CC. Químicas,
Universidad Complutense de Madrid, Madrid, Spain.
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Carsten Schmidt-Weber
Center of Allergy and Environment (ZAUM),
Technical University, and Institute of Allergy Research, Helmholtz Center Munich, Germany
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Last updated 24 November 2017